The AMPATH multiple myeloma programme model

AI in multiple myeloma: Recent findings and opportunities

Isatuximab survival benefit over VRd in transplant-ineligible newly diagnosed multiple myeloma

Optimising immunoglobulin dosing can enhance patient outcomes in multiple myeloma

Oncologists' perspectives and practices on minimal residual disease testing in multiple myeloma

The need for improved healthcare infrastructure for extranodal NK/T-cell lymphoma in Latin America

Insights into germline genetic screening of breast cancer patients

Daratumumab and lenalidomide for frail patients with newly diagnosed multiple myeloma shows promising survival results

High-fibre dietary intervention in precursor plasma cell disorders improves biomarkers of disease, may delay progression to myeloma

Lack of benefit of auto-HCT in MCL patients in first complete remission with undetectable MRD

SABCS 2024: Highlights in breast cancer genomic testing

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer